Strumento inattivo

Altre lingue BETR THER

Azioni

BTTX

US62402D1054

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

MOUN CRES : Statement of Changes in Beneficial Ownership - Form 4	19/09/22
MOUN CRES : Statement of Changes in Beneficial Ownership - Form 4	16/09/22
MOUN CRES : Statement of Changes in Beneficial Ownership - Form 4	14/09/22
MOUN CRES : Better Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update - Form 8-K	11/08/22
MOUN CRES : Better Therapeutics Completes Pivotal Trial of BT-001 for Type 2 Diabetes and Announces Positive Secondary Endpoint Results Following the Earlier Announcement of Positive Primary Endpoint Results - Form 8-K	28/07/22
MOUN CRES : Statement of Changes in Beneficial Ownership (Form 4)	07/07/22
MOUN CRES : Statement of Changes in Beneficial Ownership (Form 4)	28/06/22
MOUN CRES : Statement of Changes in Beneficial Ownership (Form 4)	17/06/22
MOUN CRES : Statement of Changes in Beneficial Ownership (Form 4)	14/06/22
MOUN CRES : Statement of Changes in Beneficial Ownership (Form 4)	11/06/22
MOUN CRES : Statement of Changes in Beneficial Ownership (Form 4)	10/06/22
MOUN CRES : Statement of Changes in Beneficial Ownership (Form 4)	10/06/22
MOUN CRES : Statement of Changes in Beneficial Ownership (Form 4)	10/06/22
MOUN CRES : Statement of Changes in Beneficial Ownership (Form 4)	10/06/22
MOUN CRES : Statement of Changes in Beneficial Ownership (Form 4)	10/06/22
MOUN CRES : Statement of Changes in Beneficial Ownership (Form 4)	10/06/22
MOUN CRES : Statement of Changes in Beneficial Ownership (Form 4)	10/06/22
MOUN CRES : Better Therapeutics Appoints Frank Karbe as Chief Executive Officer - Form 8-K	07/06/22
MOUN CRES : Statement of Changes in Beneficial Ownership (Form 4)	01/06/22
MOUN CRES : Better Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results - Form 8-K	28/03/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue BETR THER

Azioni

BTTX

US62402D1054

Altre lingue

Filtri